Bernard J Zovighian insider trades: Edwards Lifesciences (EW) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bernard reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | EW | ↓ Sell | 2,921 | $83.93 | $245K | By Trust | Jul 27, 2026 (0d) |
| Jun 17, 2026 | EW | ↓ Sell | 523 | $87.92 | $46K | By Trust | Jun 17, 2026 (0d) |
| May 12, 2026 | EW | ↓ Sell | 36,351 | $77.93 | $2.8M | By Trust | May 12, 2026 (0d) |
| Dec 10, 2025 | EW | ↓ Sell | 3,863 | $83.45 | $322K | By Trust | Dec 10, 2025 (0d) |
| Dec 8, 2025 | EW | ↓ Sell | 21,487 | $85.21 | $1.8M | Direct | Dec 10, 2025 (2d) |
| Jun 3, 2025 | EW | ↓ Sell | 17,066 | $77.22 | $1.3M | By Trust | Jun 3, 2025 (0d) |
| May 5, 2025 | EW | ↓ Sell | 5,980 | $74.91 | $448K | Direct | May 6, 2025 (1d) |
| Mar 10, 2025 | EW | ↓ Sell | 6,164 | $69.51 | $428K | Direct | Mar 10, 2025 (0d) |
| May 30, 2024 | EW | ↓ Sell | 8,617 | $87.68 | $756K | Direct | May 30, 2024 (0d) |
| May 6, 2024 | EW | ↑ Buy | 580 | $85.74 | $50K | 401(k) | May 7, 2024 (1d) |
| Aug 5, 2022 | EW | ↓ Sell | 4,811 | $103.66 | $499K | Direct | Aug 5, 2022 (0d) |
| Jun 14, 2022 | EW | ↓ Sell | 4,809 | $87.75 | $422K | Direct | Jun 14, 2022 (0d) |
| May 31, 2022 | EW | ↓ Sell | 9,000 | $100.83 | $907K | Direct | May 31, 2022 (0d) |
| May 24, 2022 | EW | ↓ Sell | 4,809 | $95.52 | $459K | Direct | May 24, 2022 (0d) |
| Apr 27, 2017 | EW | ↓ Sell | 18,050 | $109.21 | $2.0M | Direct | Apr 28, 2017 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EW insiders
Open-market trades in the last 12 months
About Bernard J Zovighian's insider trades
Bernard J Zovighian is CEO at Edwards Lifesciences (EW). Since Apr 27, 2017, Bernard has reported 1 open-market purchase worth $50K and 14 sales worth $12.5M on SEC Form 4. In the last 12 months: 5 sales ($5.3M).
Their filings also include shares withheld for taxes (15 filings), gifts (10 filings), grants and awards (9 filings), option exercises (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EW insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.